{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:45:44Z","timestamp":1782539144285,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.msard.2020.102252","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:45:59Z","timestamp":1591098359000},"page":"102252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pre-pregnancy, obstetric and delivery status in women with neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"44","author":[{"given":"Fereshteh","family":"Ashtari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Mehdipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-4153","authenticated-orcid":false,"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-0947","authenticated-orcid":false,"given":"Nasrin","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2020.102252_bib0001","doi-asserted-by":"crossref","first-page":"e01338","DOI":"10.1002\/brb3.1338","article-title":"Epidemiology of neuromyelitis optica spectrum disorder in Denmark (1998\u20132008, 2007\u20132014)","volume":"9","author":"Asgari","year":"2019","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.msard.2020.102252_bib0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/biomedicines7020042","article-title":"Neuromyelitis optica spectrum disorder and anti-MOG syndromes","volume":"7","author":"Lana-Peixoto","year":"2019","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.msard.2020.102252_bib0003","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.msard.2020.102252_bib0004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin. Med."},{"issue":"3","key":"10.1016\/j.msard.2020.102252_bib0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2020.102252_bib0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","article-title":"Pregnancy outcomes in aquaporin-4\u2013positive neuromyelitis optica spectrum disorder","volume":"86","author":"Nour","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2020.102252_bib0007","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.1301483","article-title":"Neuromyelitis optica IgG causes placental inflammation and fetal death","volume":"191","author":"Saadoun","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2020.102252_bib0008","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1007\/s13760-016-0654-x","article-title":"Neuromyelitis optica and pregnancy","volume":"116","author":"Zare-Shahabadi","year":"2016","journal-title":"Acta Neurol. Belg."},{"issue":"22","key":"10.1016\/j.msard.2020.102252_bib0009","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1212\/WNL.0000000000004681","article-title":"High risk of postpartum relapses in neuromyelitis optica spectrum disorder","volume":"89","author":"Klawiter","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102252_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1753495X18758868","article-title":"Devic syndrome and pregnancy: a case series","volume":"11","author":"Wuebbolt","year":"2018","journal-title":"Obstet. Med."},{"issue":"11","key":"10.1016\/j.msard.2020.102252_bib0011","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/1352458515583376","article-title":"Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder","volume":"22","author":"Shimizu","year":"2016","journal-title":"Multiple Sclerosis J."},{"issue":"1","key":"10.1016\/j.msard.2020.102252_bib0012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12969-018-0242-0","article-title":"Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate","volume":"16","author":"Ling","year":"2018","journal-title":"Pediatric Rheumatol."},{"issue":"12","key":"10.1016\/j.msard.2020.102252_bib0013","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/art.1780341210","article-title":"Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience","volume":"34","author":"Petri","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"5\u20136","key":"10.1016\/j.msard.2020.102252_bib0014","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/08820130802205886","article-title":"Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy","volume":"37","author":"Adams Waldorf","year":"2008","journal-title":"Immunol. Invest."},{"issue":"6","key":"10.1016\/j.msard.2020.102252_bib0015","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1212\/NXI.0000000000000288","article-title":"Immunology of neuromyelitis optica during pregnancy","volume":"3","author":"Davoudi","year":"2016","journal-title":"Neurol.-Neuroimmunol. Neuroinfl."},{"key":"10.1016\/j.msard.2020.102252_bib0016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.msard.2018.07.006","article-title":"Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"25","author":"Tong","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2020.102252_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102252_bib0018","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2020.102252_bib0019","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1756285616632653","article-title":"An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica","volume":"9","author":"Collongues","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"11","key":"10.1016\/j.msard.2020.102252_bib0020","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","article-title":"Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years","volume":"68","author":"Kim","year":"2011","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2020.102252_bib0021","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s13167-018-0143-9","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies","volume":"9","author":"Borisow","year":"2018","journal-title":"EPMA Journal"},{"key":"10.1016\/j.msard.2020.102252_bib0022","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.msard.2018.08.015","article-title":"Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica","volume":"25","author":"Delgado-Garc\u00eda","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102252_bib0023","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jns.2016.11.054","article-title":"Pregnancy in neuromyelitis optica spectrum disorder: a multicenter study from South China","volume":"372","author":"Huang","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"16","key":"10.1016\/j.msard.2020.102252_bib0024","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.0b013e318250d812","article-title":"Influence of pregnancy on neuromyelitis optica spectrum disorder","volume":"78","author":"Kim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102252_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2017.03.051","article-title":"Effectiveness and safety of immunosuppressive therapy in neuromyelitis optica spectrum disorder during pregnancy","volume":"377","author":"Shi","year":"2017","journal-title":"J. Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:49:07Z","timestamp":1761900547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482030328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":25,"alternative-id":["S221103482030328X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102252","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-pregnancy, obstetric and delivery status in women with neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102252"}}